Antagonists selective for estrogen receptor α

Endocrinology

Volumn 143, Issue 3, 2002, Pages 941-947

  Sun, Jun ^a   Huang, Ying R ^b   Harrington, William R ^a   Sheng, Shubin ^a   Katzenellenbogen, John A ^b   Katzenellenbogen, Benita S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; HYDROXYTAMOXIFEN; MESSENGER RNA; METHYLPIPERIDINOPYRAZOLE; PYRAZOLE DERIVATIVE; RALOXIFENE; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN MCF 7; CONSENSUS SEQUENCE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR AFFINITY; REPORTER GENE;

EID: 0036177151     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.3.8704     Document Type: Article

References (33)

1. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
2. ERβ: Identification and characterization of a novel human estrogen receptor
3. Role of estrogen receptor β in estrogen action
4. Estrogen receptors α and β: Two receptors of a kind?
5. Estrogen receptors: Selective ligands, partners, and distinctive pharmacology
6. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β
7. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists
8. Estrogen receptor null mice: What have we learned and where will they lead us?
9. The molecular pharmacology of SERMs
10. Estrogen receptor α and estrogen receptor β: Regulation by selective estrogen receptor modulators (SERMs) and importance in breast cancer
11. Pyrazole ligands: Structure-affinity/activity relationships of estrogen receptor-α selective agonists
12. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-α and estrogen receptor-β: Correlations with biological character and distinct differences among SRC coactivator family members
13. A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ERα
14. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β
15. Estrogen receptor subtype-selective ligands: Asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl-5,6,11,12-tetrahydrochrysenes
16. Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors α and β
17. Estrogen receptor-β potency-selective ligands: Structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogs
18. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast
19. Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras
20. The carboxyl-terminal F domain of the human estrogen receptor: Role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists
21. + exchanger regulatory factor
22. + exchanger regulatory factor (nhe-Rf) gene
23. Regioselective synthesis of 1,3,5-triaryl4-alkylpyrazoles: Novel ligands for the estrogen receptor
24. Triarylpyrazoles with basic side chains: Development of pyrazole-based estrogen receptor antagonists
25. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: Evidence that an open pocket conformation is required for ligand interaction
26. Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors
27. Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines
28. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: Comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells
29. Estrogen pyrazoles: Defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptor
30. Identification of an estrogen response element activated by metabolites of 17-β-estradiol and raloxifene
31. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs
32. Human estrogen receptorβ-specific monoclonal antibodies: Characterization and use in studies of estrogen receptor β protein expression in reproductive tissues
33. 50) of an enzymatic reaction